Kisunla (donanemab-azbt) is now approved by the FDA for adults with early symptomatic Alzheimer disease. Eli Lilly and Company psychiatrictimes.com/view/alzheimer…

We are currently recruiting participants for a research study to assess the safety and efficacy of a digital therapeutic in adults with negative symptoms of schizophrenia. For more information, contact [email protected] or call us at 860.545.7476

SAINT iTBS Protocol Shows Promise for Bipolar I Depression psychiatrictimes.com/view/saint-itb… via @Psychiatric Times

Posters Share Positive Data on Long-Term Treatment with Xanomeline/Trospium psychiatrictimes.com/view/posters-s… via @Psychiatric Times

A small trial suggests psilocybin, paired with psychological support, could be a safe and tolerable anorexia treatment.via=psychiatristcns psychiatrist.com/news/psilocybi…

New research shows that hyperbaric oxygen therapy could significantly reduce PTSD symptoms in veterans resistant to standard treatments.via=psychiatristcns psychiatrist.com/news/hyperbari…

Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium: A Retrospective Study psychiatrist.com/jcp/intravenou…

FDA Approves Spravato Nasal Spray as Monotherapy for Treatment Resistant Major Depressive Disorder psychiatrist.com/news/fda-appro…

Esketamine Nasal Spray vs Quetiapine Extended-Release: Examining Work Productivity Loss and Related Costs in Patients With Treatment-Resistant Depression psychiatrist.com/jcp/esketamine…

The February issue of Psychiatric Times is now live! This month, we take closer look at media excess and its impact on our mental health. Download the issue now and follow along as articles are shared throughout the month. cdn.sanity.io/files/0vv8moc6…

Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study psychiatrist.com/jcp/long-term-…

Brexpiprazole and Sertraline for Posttraumatic Stress Disorder jamanetwork.com/journals/jamap…

New Therapies Target NMDARs to Improve Schizophrenia Symptoms psychiatrist.com/news/new-thera…

Xanomeline and Trospium Chloride for the Treatment of Agitation Associated With Schizophrenia: PANSS-Excited Component Results From 3 Randomized, Double-Blind, Placebo-Controlled EMERGENT Trials psychiatrist.com/jcp/xanomeline…

TSND-201 Receives Breakthrough Therapy Designation From FDA for PTSD psychiatrictimes.com/view/tsnd-201-… via @@psychtimes

Psych News Alert: Esketamine Monotherapy Outperforms Placebo for Treatment-Resistant Depression: alert.psychnews.org/2025/07/esketa…

US FDA advisers recommend against Otsuka's PTSD combination treatment reuters.com/business/healt…

Residential Intensive Short-Term Dynamic Psychotherapy, Part 1: Accelerating the Treatment of Personality Disorders | American Journal of Psychotherapy psychiatryonline.org/doi/10.1176/ap…

Metformin Shows Promise for Cognition in Schizophrenia Trial psychiatrist.com/news/metformin…

Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis - The Lancet Public Health thelancet.com/journals/lanpu…